Vericel Corp. (VCEL)
42.36
-0.32
(-0.76%)
USD |
NASDAQ |
Aug 24, 16:00
42.36
0.00 (0.00%)
After-Hours: 19:27
Vericel Price : 42.36 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 42.36 | 42.85 | 41.76 | 42.68 | 647128.0 |
| Aug 20, 2026 | 42.83 | 43.48 | 41.68 | 42.11 | 567686.0 |
| Aug 19, 2026 | 45.04 | 46.01 | 42.89 | 43.57 | 630188.0 |
| Aug 18, 2026 | 43.59 | 45.38 | 43.59 | 44.26 | 549697.0 |
| Aug 17, 2026 | 43.75 | 44.31 | 43.41 | 43.59 | 276261.0 |
| Aug 14, 2026 | 44.53 | 44.55 | 43.65 | 44.20 | 276054.0 |
| Aug 13, 2026 | 45.34 | 46.13 | 43.74 | 44.54 | 527894.0 |
| Aug 12, 2026 | 44.11 | 44.90 | 43.66 | 44.73 | 290767.0 |
| Aug 11, 2026 | 44.30 | 45.27 | 44.01 | 44.35 | 416861.0 |
| Aug 10, 2026 | 44.48 | 44.82 | 43.15 | 43.95 | 415810.0 |
| Aug 07, 2026 | 44.83 | 45.56 | 44.35 | 45.09 | 472912.0 |
| Aug 06, 2026 | 45.18 | 45.40 | 44.33 | 44.75 | 334657.0 |
| Aug 05, 2026 | 46.19 | 46.86 | 44.98 | 45.36 | 468924.0 |
| Aug 04, 2026 | 45.79 | 46.50 | 45.11 | 46.34 | 440831.0 |
| Aug 03, 2026 | 45.98 | 47.27 | 45.96 | 46.05 | 497961.0 |
| Jul 31, 2026 | 46.97 | 47.11 | 45.17 | 45.96 | 521462.0 |
| Jul 30, 2026 | 48.90 | 49.32 | 46.31 | 47.61 | 988551.0 |
| Jul 29, 2026 | 46.00 | 47.07 | 45.68 | 46.62 | 505569.0 |
| Jul 28, 2026 | 45.84 | 47.00 | 45.79 | 46.71 | 433574.0 |
| Jul 27, 2026 | 45.48 | 46.14 | 45.21 | 45.32 | 394660.0 |
| Jul 24, 2026 | 46.14 | 46.14 | 44.69 | 45.05 | 360450.0 |
| Jul 23, 2026 | 44.24 | 45.19 | 43.95 | 45.04 | 715028.0 |
| Jul 22, 2026 | 46.03 | 46.39 | 44.56 | 44.56 | 383711.0 |
| Jul 21, 2026 | 45.50 | 46.34 | 45.04 | 46.14 | 504374.0 |
| Jul 20, 2026 | 46.55 | 46.90 | 45.79 | 45.88 | 637095.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Krystal Biotech, Inc. | 341.78 |
| AbbVie, Inc. | 264.49 |
| Marker Therapeutics, Inc. | 1.50 |
| TG Therapeutics, Inc. | 56.05 |
| ADMA Biologics, Inc. | 9.545 |
Price Related Metrics
| PE Ratio | 91.62 |
| PS Ratio | 7.158 |
| PEG Ratio | 0.3380 |
| Price to Book Value | 5.857 |
| Price to Free Cash Flow | 35.56 |
| Earnings Yield | 1.09% |
| Market Cap | 2.167B |
| PEGY Ratio | 0.3380 |
| Operating PE Ratio | 120.24 |
| Normalized PE Ratio | 91.64 |